Introduction

•
The objectives of treatment in hypoparathyroidism are controlling symptoms and maintaining serum calcium in the low-normal range and serum phosphorus within a normal range without developing hypercalciuria and nephrocalcinosis.
• We present a case who has hypocalcemia and hyperphosphatemia and also nephrocalcinosis.
Case Report
Medical history
• A fifty-years old man was admitted to hospital for routine visit .
• At the age of 24, in Neurology department basal ganglion calcification was diagnosed caused by hypoparathyroidism.
• • Vitamin D treatment results in further hypercalciuria and nephrocalcinosis..
• Some literature suggests the use of injectable parathormon(1-34) when nephrocalcinosis developed in the treatment of hypoparathyroidism but some results showed no difference when compared with conventional therapy.
• In addition, parathormon is not approved by FDA for use in hypoparathyroidism in USA because of the unknown risk of osteosarcoma.
• In Turkey we can only use as a drug except of indication with the permission of Health Ministry.
• In this case: changing medical treatment to more potent calcitriol which has a rapid onset and offset rather than Vit D provided us to keep serum calcium level near the lower limit and also some degree of improvement in nephrocalcinosis.
